This guide verifies how both medical abortion medications are administered, timing, possible side effects, and follow-up clinic appointments. It also covers symptoms that require prompt attention, and what the patient should do in this case. This simple and graphic guide is a piece accompanying the patient contract and medication guide. The doctor must sign and return the prescriber`s agreement; The patient should read and sign the patient agreement and read the medication guide. Day 1: mifepriston 200mg in single oral dose. Day 2 or 3: misoprostol 800mcg buccally within 24-48 hours after the dose of Mifepriston. Day 7-14: Confirm that the complete termination of the pregnancy was done by a clinical examination or ultrasound. This booklet answers questions that are generally asked about medical abortion, treatment of use, safety, effectiveness, and risk. It aims to reduce the concerns and fears of patients seeking a medical abortion.
It also helps patients understand that they are not alone and that medical abortion will end to help millions of patients stop early pregnancy in a safe and effective way. Risk of serious infections or bleeding. Only by or under the supervision of doctors who have signed and returned the prescriber`s agreement; be able to assess the pregnancy age of the embryo and diagnose an ectopic pregnancy; Have access to emergency treatment facilities for incomplete abortion, severe bleeding or resuscitation; and meet storage, dose tracking, etc. requirements. If mifepriston and misoprostol fail, make a surgical interruption. Exclude ectopic pregnancy before treatment in patients with IUD. Rhesus vaccination prevention methods should be used. Hemostatic disorders. Hypocoagulation. Severe anaemia.
Pregnancy: Failure of treatment can lead to fetal malformations. Breastfeeding mothers: see full labelling. Use our practical support to inform your patients about medical abortions and what you can expect, to improve respect and success and provide comfort in a stressful time. GenBioPro offers these readable and easy-to-read “before and after” instructions for patients for your application: Home > Resources > Mifepristone Distributor Patient Agreement Ectopic Pregnancy or undiagnosed Adnexalmasse. IUD on the spot. Chronic failure of the adrenal gland. Allergy of prostaglandin. Hemorrhagic disorders. Hereditary porphyria. Long-term concomitant corticosteroids or anticoagulant treatment. These tools are designed to help primary care physicians integrate reproductive health care into their own practice.
These tools are also integrated into the practice chapter of the work record office. Here you can use genBioPro (generic) and Danco (brands, Mifeprex) forms that doctors should use when using abortion drugs with mifepriston. See the contraindications. Can potentiate the substrates of CYP3A4. Can be potentiated by ketoconazole, itraconazole, erythromycin, grapefruit juice. Can be antagonized by rifampine, dexamethasone, St. John`s wort, phenytoin, phenobarbital, carbamazepine.